Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, andABCB1-Reference-Cited by-同舟云学术

Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, andABCB1

Published:2016-06-21 Issue:12 Volume:56 Page:1570-1581
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Powers Jennifer L.¹,Buys Saundra S.²,Fletcher Deborah³,Melis Roberta⁴,Johnson-Davis Kamisha L.¹⁴,Lyon Elaine¹⁴,Malmberg Elisabeth M.⁴,McMillin Gwendolyn A.¹⁴

Affiliation:

1. Department of Pathology; University of Utah; Salt Lake City UT USA

2. Department of Medicine; Huntsman Cancer Institute; University of Utah Health Sciences Center; Salt Lake City UT USA

3. Department of Pharmacy; Huntsman Cancer Institute; University of Utah Health Sciences Center; Salt Lake City UT USA

4. ARUP Institute for Clinical and Experimental Pathology; Salt Lake City UT USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference35 articles.

1. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial;Davies;Lancet.,2013

2. Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials;Davies;Lancet.,2011

3. Tamoxifen in the treatment of breast cancer;Osborne;N Engl J Med.,1998

4. Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen;Johnson;Breast Cancer Res Treat.,2004

5. Pharmacogenomics of tamoxifen: roles of drug metabolizing enzymes and transporters;Kiyotani;Drug Metab Pharmacokinet.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cholesteryl ester transfer protein knock‐down in conjunction with a cholesterol‐depleting agent decreases tamoxifen resistance in breast cancer cells;IUBMB Life;2024-05-11

2. Influence of CYP2D6 and its polymorphic forms on the metabolism of tamoxifen in therapy of luminal forms of breast cancer;Reports of Vinnytsia National Medical University;2024-03-14

3. Impact of CYP2D6, CYP2C9/19, CYP3A4, UGT, and SULT Variability on Tamoxifen Metabolism in Breast Cancer Treatment;Journal of Current Oncology;2024-02-27

4. Pharmacogenetics of Breast Cancer Treatments: A Sub-Saharan Africa Perspective;Pharmacogenomics and Personalized Medicine;2022-06

5. Generating a Precision Endoxifen Prediction Algorithm to Advance Personalized Tamoxifen Treatment in Patients with Breast Cancer;Journal of Personalized Medicine;2021-03-13